Bevacizumab Plus Interferon Alfa Compared With Interferon Alfa Monotherapy in Patients With Metastatic Renal Cell Carcinoma: CALGB 90206Brian I. Rini, Eric J. Small|Journal of Clinical Oncology|2008Cited by 907
Antiandrogen Withdrawal Alone or in Combination With Ketoconazole in Androgen-Independent Prostate Cancer Patients: A Phase III Trial (CALGB 9583)Eric J. Small, Nicholas J. Vogelzang, Susan Halabi et al.|Journal of Clinical Oncology|2004Cited by 502
Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer ConsortiumPetros Grivas, Shuchi Gulati, Donna R. Rivera et al.|Annals of Oncology|2021Cited by 326
Clinical activity of nivolumab in patients with non-clear cell renal cell carcinomaVadim S. Koshkin, Brian I. Rini, Pedro C. Barata et al.|Journal for ImmunoTherapy of Cancer|2018Cited by 184
Utilization of COVID-19 Treatments and Clinical Outcomes among Patients with Cancer: A COVID-19 and Cancer Consortium (CCC19) Cohort StudyDonna R. Rivera, Jeremy L. Warner, Solange Peters et al.|Cancer Discovery|2020Cited by 138